Bioage Labs Inc. share price logo

Bioage Labs Inc. Share Price

NASDAQ: BIOA

Small Cap

$4.79

-0.01

(-0.21%)

as on

Bioage Labs Inc. Stock Performance

as on September 16, 2025 at 1:29 am IST

  • Day's Low

    Day's High

    $4.7
    $4.92
    downward going graph

    1.88%

    Downside

    2.71%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $2.88
    $26.62
    downward going graph

    39.87%

    Downside

    455.74%

    Upside

    downward going graph

Bioage Labs Inc. share price movements today

Previous Close
$4.80
Open
$4.90
Volume
697.8K
Day's Low - High
$4.7 - $4.92
52 Week Low - High
$2.88 - $26.62

Bioage Labs Inc. Historical Returns

1 Month Return
+ 5.49 %
3 Month Return
+ 6.19 %
1 Year Return
0 %
3 Year Return
0 %
5 Year Return
0 %

Bioage Labs Inc. Stock Fundamentals & Key Indicators

Check Bioage Labs Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$172.1M

EPS (TTM)

-2.0115

Dividend Yield

0.00%

PE Ratio (TTM)

0

P/B Ratio

0

PEG Ratio

0

Return On Equity TTM

2851000.00%

Bioage Labs Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Bioage Labs Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
NA$172.1MNANA0.00%
BUY$18.3BNA15.840.36%
BUY$44.1BNA21.813.81%
BUY$14.1B36.02%41.9713.88%
BUY$65.7B-8.68%25.5127.83%

Stock Returns calculator for Bioage Labs Inc. Stock including INR - Dollar returns

The Bioage Labs Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 10Y

Bioage Labs Inc. investment value today

Current value as on today

₹1,18,149

Returns

₹18,149

(+18.15%)

Returns from Bioage Labs Inc. Stock

₹14,158 (-14.16%)

Dollar Returns*

₹32,306 (+32.31%)

Bioage Labs Inc. Stock's Interest Amongst Investors

Search interest for Bioage Labs Inc. Stock has increased by 80% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:80% versus previous 30 day period

Bioage Labs Inc. Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
-
-
-
-
-
-
-
-
1
2
Gross Profit
-
-
-
-
-
-
-
-
1
2
Operating Income
-11
-13
-9
-13
-12
-15
-24
-25
-16
-24
EBITDA
-10
-15
-12
-18
-11
-13
-22
-20
-16
-21
Interest Expense
0
2
2
2
1
0
0
0
0
0
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-11
-17
-14
-20
-12
-13
-23
-21
-12
-21
Income Tax Expense
0
2
-
-
1
0
-
-
-
-
Net Income
-11
-17
-14
-20
-12
-13
-23
-21
-12
-21
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
-890.97%
-893.99%

Bioage Labs Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2013
Dec 2014
Dec 2015
Dec 2016
Dec 2017
Dec 2022
Dec 2023
Dec 2024
Total Revenue
2
1
2
8
14
-
-
-
Gross Profit
0
-4
0
-5
-7
-
-
-
Operating Income
-41
-35
-38
-29
-110
-39
-48
-78
EBITDA
-38
-44
-33
-13
-88
-39
-55
-78
Interest Expense
7
-
-
-
-
0
7
2
Depreciation
-
-
-
-
-
0
0
0
Income Before Tax
-33
-47
-41
-28
-102
-39
-63
-71
Income Tax Expense
0
0
0
0
0
0
7
-71
Net Income
-33
-46
-37
-22
-98
-39
-63
-71
Net Profit Margin
-1246.33%
-3008.45%
-1713.94%
-271.72%
-656.84%
0.00%
0.00%
0.00%

Bioage Labs Inc. Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
-17
-14
-20
-12
-13
-23
-21
-12
-21
Operating Cash Flow
-11
-7
-8
-15
-15
-14
-5
-17
-19
Investing Cash Flow
0
0
-
-
0
0
0
-77
-15
Financing Cash Flow
12
0
-1
168
-2
190
24
-1
-1
Change in Cash
1
-7
-9
152
-18
175
19
-96
-37

Bioage Labs Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2014
Dec 2015
Dec 2016
Dec 2017
Dec 2022
Dec 2023
Dec 2024
Net Income
-46
-37
-22
-98
-39
-63
-71
Operating Cash Flow
-22
-32
-37
-29
-36
-37
-51
Investing Cash Flow
-
-
-
-
0
0
0
Financing Cash Flow
78
54
47
18
2
34
381
Change in Cash
-32
-44
9
-11
-33
-2
329

Insights on Bioage Labs Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, BIOA stock has moved down by -3.6%

About Bioage Labs Inc.

BioAge Labs, Inc. is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging. Its lead product is BGE-102, a structurally novel, orally available small molecule NLRP3 inhibitor with high potency and brain penetration. In preclinical obesity models, BGE-102 resulted in weight loss as both a monotherapy and in combination with a GLP-1R agonist. Its pipeline includes novel, orally available, brain-penetrant small-molecule NLRP3 inhibitors to treat metabolic diseases and conditions driven by neuroinflammation, as well as novel APJ agonists for metabolic disorders. In preclinical obesity models, APJ agonism has demonstrated the ability to more than double the weight loss induced by a GLP-1R agonist while also restoring healthy body composition and improving muscle function.
OrganisationBioage Labs Inc.
Headquarters1445A South 50th Street, Richmond, CA, United States, 94804
CEODr. Kristen Fortney Ph.D.
E-voting on sharesClick here to vote

Key Management of Bioage Labs Inc.

Name

Title

Dr. Dov A. Goldstein M.B.A., M.D.

Chief Financial Officer

Ms. Julie Gammelgard

Senior Vice President of People

Dr. Carrie-Lynn Langlais Furr

Senior Vice President of Regulatory Affairs

Mr. Justin Rebo

Senior Vice President of Translational Aging Biology

Mr. BJ Sullivan Ph.D.

Chief Strategy Officer

Dr. Paul D. Rubin M.D.

Chief Medical Officer & Executive VP of Research

Mr. Eric Morgen M.D.

Co-Founder, COO & Director

Mr. Rusty Montgomery Ph.D.

Senior Vice President of Research

Dr. Peng Leong M.B.A., Ph.D.

Chief Business Officer & Therapeutic Area Head of Brain Aging

Dr. Kristen Fortney Ph.D.

Co-Founder, CEO, President, Treasurer, Secretary & Director

FAQs

What is Bioage Labs Inc. share price today?

Bioage Labs Inc. share price today is $4.79 as on at the close of the market. Bioage Labs Inc. share today touched a day high of $4.92 and a low of $4.7.

What is the 52 week high and 52 week low for Bioage Labs Inc. share?

Bioage Labs Inc. share touched a 52 week high of $26.62 on and a 52 week low of $2.88 on . Bioage Labs Inc. stock price today i.e. is closed at $4.79,which is 82.01% down from its 52 week high and 66.32% up from its 52 week low.

What is Bioage Labs Inc.'s market capitalisation today?

Bioage Labs Inc. market capitalisation is $0.00T as on .

How to invest in Bioage Labs Inc. Stock (BIOA) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Bioage Labs Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Bioage Labs Inc. Shares that will get you 0.3132 shares as per Bioage Labs Inc. share price of $4.79 per share as on September 16, 2025 at 1:29 am IST.

What is the minimum amount required to buy Bioage Labs Inc. Stock (BIOA) from India?

Indian investors can start investing in Bioage Labs Inc. (BIOA) shares with as little as ₹88.141 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹881.41 in Bioage Labs Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Bioage Labs Inc. share’s latest price of $4.79 as on September 16, 2025 at 1:29 am IST, you will get 2.0877 shares of Bioage Labs Inc.. Learn more about fractional shares .